Pinned Tweet
I recommend everyone to go A-Z.
With this article I try to explain how I did it, what I found and why I think it was a valuable exercise.
Link in bio or below.
Saesch retweeted
I've been using @Journalytic on and off for the last few years, but in an age of AI, the value of recording all your investment decisions is incredibly high and is compounding at higher rates. My prediction is that in 10 years, if you don't have good data on your past decisions, you'll become obsolete.
Why? Because other people who have will be able to gett much better outputs from an AI workflow.
Thanks to @atomicalcapital for opening my eyes to this. My interview with him will be out in a month or so, and I believe it will be extremely helpful for most serious investors.
Saesch retweeted
#MACF - Interims
➡️1H Rev up 2%, adj PBT down 9%, divi held flat.
➡️Net debt up to £17.9m - "investment in inventory"
➡️£6m buyback beginning in October from debt.
➡️FY trading in line & outlook runs through conditional activity that will deliver results.
Saesch retweeted
#VLX - AGM TU
✅Another upgrade as "the Board now expects FY27 adj op profit to be ahead of current market expectations"
✅YTD Rev up 28.0%, albeit the company guides monthly sequential trading YTD up 8% vs 2H FY26.
✅Data Centre demand sustained at elevated exit rate of FY26.
Saesch retweeted
It seems like to board of $CARD.L want to keep their job. Finally a buyback...
At current price that will be super acretative.
We have today confirmed our intention to move to the @LSEplc Main Market by 4 August 2026, subject to FCA approval.
We have also announced the launch of a £40 million share buyback programme.
Read the full details here: volex.com/investors
In case someone has any questions regarding my A-Z journey on AIM, about AIM itself, the process, ... let me know, I'll answer them in my wrap-up next week.
5x watchlist today. We also come across #VLX. Even the tickers I passed on might be interesting: turnaround case, an wine retailer with a big buyback program and UK’s leading bathroom retailer. I’d say this is the best part of the whole series.
Link in bio or below.
Today, a pharma distributor with over 50% market share in its home market, with ambitious growth plans and a good track record. #UPR
Link in bio or below.

















